Business Description
Ensol Biosciences Inc
ISIN : KR7140610007
Compare
Compare
Traded in other countries / regions
140610.Korea IPO Date
2018-09-10Description
Ensol Biosciences Inc is a Korean big data-driven biopharmaceutical company. The company is engaged in developing drugs for the diseases that have no therapeutic alternatives, such as a degenerative disc, osteoarthritis, cancer, Alzheimer's dementia, and type 1 diabetes. Its drugs portfolio includes Peniel 2000 Drug for Degenerative Disc Disease, Engedi 1000 Drug for Osteoarthritis, Charis 1000 Drug for Immuno-Oncology, Moriah 1000 Drug for Alzheimer's Disease, Shiloah 1000 Drug for Type I Diabetes, and EAD100 Drug for Animal Osteoarthritis.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.52 | |||||
| Equity-to-Asset | -0.58 | |||||
| Debt-to-Equity | -1.57 | |||||
| Debt-to-EBITDA | -0.89 | |||||
| Piotroski F-Score | 1/9 | |||||
| Altman Z-Score | -10.03 | |||||
| Beneish M-Score | -3.17 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -37.6 | |||||
| 3-Year EBITDA Growth Rate | 6.8 | |||||
| 3-Year EPS without NRI Growth Rate | -4 | |||||
| 3-Year FCF Growth Rate | -7 | |||||
| 3-Year Book Growth Rate | -15.1 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 58.51 | |||||
| 9-Day RSI | 55.48 | |||||
| 14-Day RSI | 57.06 | |||||
| 6-1 Month Momentum % | 182.38 | |||||
| 12-1 Month Momentum % | 14.95 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.38 | |||||
| Quick Ratio | 0.38 | |||||
| Cash Ratio | 0.36 | |||||
| Days Inventory | 2183.94 | |||||
| Days Sales Outstanding | 92.86 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6.6 | |||||
| Shareholder Yield % | -4.36 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 73.25 | |||||
| Operating Margin % | -5421.39 | |||||
| Net Margin % | -6401.82 | |||||
| FCF Margin % | -4648.12 | |||||
| ROA % | -100.37 | |||||
| ROIC % | -50.37 | |||||
| ROC (Joel Greenblatt) % | -230.12 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 758.63 | |||||
| EV-to-EBIT | -13.71 | |||||
| EV-to-EBITDA | -14.53 | |||||
| EV-to-Revenue | 789.04 | |||||
| EV-to-FCF | -17.11 | |||||
| Earnings Yield (Greenblatt) % | -7.29 | |||||
| FCF Yield % | -6.07 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ensol Biosciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 176.545 | ||
| EPS (TTM) (â‚©) | -1054 | ||
| Beta | 0.87 | ||
| Volatility % | 126.16 | ||
| 14-Day RSI | 57.06 | ||
| 14-Day ATR (â‚©) | 748.493 | ||
| 20-Day SMA (â‚©) | 12522 | ||
| 12-1 Month Momentum % | 14.95 | ||
| 52-Week Range (â‚©) | 2800 - 13290 | ||
| Shares Outstanding (Mil) | 10.83 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ensol Biosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ensol Biosciences Inc Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Ensol Biosciences Inc Frequently Asked Questions
What is Ensol Biosciences Inc(XKRX:140610)'s stock price today?
The current price of XKRX:140610 is â‚©12490.00. The 52 week high of XKRX:140610 is â‚©13290.00 and 52 week low is â‚©2800.00.
When is next earnings date of Ensol Biosciences Inc(XKRX:140610)?
The next earnings date of Ensol Biosciences Inc(XKRX:140610) is .
Does Ensol Biosciences Inc(XKRX:140610) pay dividends? If so, how much?
Ensol Biosciences Inc(XKRX:140610) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers